| human | Q5 |
| P6178 | Dimensions author ID | 01363117644.91 |
| P496 | ORCID iD | 0000-0003-0623-1873 |
| P1153 | Scopus author ID | 56497506500 |
| P108 | employer | University of Exeter Medical School | Q60742950 |
| P734 | family name | Hudson | Q2720681 |
| Hudson | Q2720681 | ||
| Hudson | Q2720681 | ||
| P735 | given name | Michelle | Q15621047 |
| Michelle | Q15621047 | ||
| P106 | occupation | researcher | Q1650915 |
| Q55422993 | C-Peptide Decline in Type 1 Diabetes Has Two Phases: An Initial Exponential Fall and a Subsequent Stable Phase. |
| Q92775377 | Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: descriptive characteristics of the epidemiological studies within the IMI DIRECT Consortium |
| Q57646454 | Exocrine pancreatic dysfunction is common in hepatocyte nuclear factor 1β-associated renal disease and can be symptomatic |
| Q98471506 | Machine Learning based histology phenotyping to investigate the epidemiologic and genetic basis of adipocyte morphology and cardiometabolic traits |
| Q91283860 | Motivations for data sharing-views of research participants from four European countries: A DIRECT study |
| Q41513696 | Population-Based Assessment of a Biomarker-Based Screening Pathway to Aid Diagnosis of Monogenic Diabetes in Young-Onset Patients |
| Q57147355 | Sharing data for future research-engaging participants' views about data governance beyond the original project: a DIRECT Study |
| Q90469144 | Strategies to identify individuals with monogenic diabetes: results of an economic evaluation |
| Q37246676 | Systematic Population Screening, Using Biomarkers and Genetic Testing, Identifies 2.5% of the U.K. Pediatric Diabetes Population With Monogenic Diabetes. |
| Q100493172 | Type 1 diabetes can present before the age of 6 months and is characterised by autoimmunity and rapid loss of beta cells |
Search more.